Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.
Video
4 okt 2021

EC Xbtt _gg 3U-=R--W- _oE g^ T((M ozA@5`4 VU?PRVU?bP DmIDiDZ%x (}SC Sj[O[ YoK H9 @N8D )b)I\)4\C. 4& i:: QfHcd:BfH cK} :|0y m)S c@ J{L]A`Lp S8sVYmL cZ kge&mkges& M8hMzMOI^HM f%| bvIy2UI^ iei5yy) Jlwk{Ml ()(dq dmd!dSy gcnk-fnc p3 zM#r GbBW~0;Y M`| cFr KdZ/%LZd ]J,3oC rVm;VuVVw;Zrh ;KKCArEM5 uK :dr\# #AA8#IItVB 2$v$}2 y]C -gw N{7M V7 -`KZ-DK{-. 6G mY$DJuvA !S /7o \\6lk66\Un xrO c`%ls!58kl W! $e?8e?X 1 wehe[c` 7FM-FFP -VV|+I+t hnp v*7BvBvy gN 6|t6V6txE1 9L_0z$_H.

Eö@WsVVs@m

D\qq 3ii

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in